Page 11 - Portable Ultrasonic Therapeutic Devices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Portable ultrasonic therapeutic devices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Portable Ultrasonic Therapeutic Devices Today - Breaking & Trending Today

NanoVibronix Receives Registration Approval for UroShield From TGA Australia

NanoVibronix Receives Registration Approval for UroShield From TGA Australia
ibtimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com.au Daily Mail and Mail on Sunday newspapers.

New York , United States , H Efa , Toni Hill , Brian Murphy , Dukehill Healthcare Pty Ltd , Health Care Facilities Hospital , Exchange Commission , Company Annual Report On Form , Company Uroshield , Nanovibronix Inc , Therapeutic Goods Administration , Signs Agreement , Dukehill Healthcare , Surface Acoustic Wave , Portable Ultrasonic Therapeutic Devices , Australian Regulatory , Therapeutic Devices , Chief Executive Officer , Managing Director , Minimally Invasive , Clinically Efficacious , Health Care Facilities , Aged Care , Annual Report , Quarterly Reports ,

NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield

(NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has expanded its reimbursement approval of the company’s PainShield™ product by adding the device to its Durable Medical Equipment (DME) schedule.
Effective immediately, PainShield is reimbursable as an approved medical device under a unique reimbursement code assigned by CMS for low frequency ultrasonic diathermy treatment specifically for home use. The product is currently the only device approved for reimbursement under the unique HCPCS code K1004, which was established through the company’s efforts and work with CMS. Visit ....

Brian Murphy , Us Centers For Medicare , Medicaid Services , Nanovibronix Inc , Surface Acoustic Wave , Portable Ultrasonic Therapeutic Devices , Durable Medical Equipment , Nasdaq Naov , Nanovibronix Inc , பிரையன் மர்பி , எங்களுக்கு மையங்கள் க்கு மருத்துவ , மருத்துவ உதவி சேவைகள் , மேற்பரப்பு ஒலி அலை , போர்டபல் மீயொலி சிகிச்சை சாதனங்கள் , நீடித்த மருத்துவ உபகரணங்கள் ,

NanoVibronix Announces Start of Real World Patient Study of UroShield

., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that an independent, real world patient study of its UroShield has commenced at Southampton University Health Sciences in partnership with Southern Health NHS Foundation Trust, an NHS health service provider of community services in the United Kingdom.
“This is another step forward in our efforts towards NHS fully adopting UroShield as a unique preventative device,” stated Brian Murphy, CEO of NanoVibronix. “We are eager to receive the results of this independent study as there are an estimated 100,000 patients living in community settings in the U.K. who are reliant on indwelling catheters and at risk of developing a catheter-associated urinary tract infection (CAUTI). There are also an additional 154,000 patients hospitalized annually who are catheterized for more than 48 hours and ....

New York , United States , H Efa , United Kingdom , Brian Murphy , Exchange Commission , Company Annual Report On Form , Southern Health , Southampton University Health Sciences , Nanovibronix Inc , Surface Acoustic Wave , Portable Ultrasonic Therapeutic Devices , Annual Report , Quarterly Reports , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஏச் எபா , ஒன்றுபட்டது கிஂக்டம் , பிரையன் மர்பி , பரிமாற்றம் தரகு , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , தெற்கு ஆரோக்கியம் , மேற்பரப்பு ஒலி அலை , போர்டபல் மீயொலி சிகிச்சை சாதனங்கள் , ஆண்டு அறிக்கை , காலாண்டு அறிக்கைகள் ,

NanoVibronix, Inc.: NanoVibronix Reports Schedule Published by NICE for Review of UroShield Device

NanoVibronix, Inc.: NanoVibronix Reports Schedule Published by NICE for Review of UroShield Device
Provides Milestones for Attaining NICE Guidance, Including Addition of UroShield to the NHS Supply Chain; Process Completion and Recommendation Expected in Q1 2022
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield, PainShield and WoundShield Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has received documentation from the National Institute for Health and Care Excellence (NICE) that outlines the timeline for NICE s review and recommendation of the company s UroShield device.
Publication of the approval schedule and timeline more clearly codifies the process that the company believes will ultimately lead to a positive recommendation of the device by NICE adoption by the National Health Service (NHS) as a clinically effective and cost saving medical device and addition of the device to the ....

New York , United States , H Efa , Brian Murphy , Brett Maas , Company Annual Report On Form , National Institute For Health , Exchange Commission , Coventry University Assistant Professor , Nanovibronix Inc , National Health Service , Provides Milestones , Including Addition , Process Completion , Recommendation Expected , Woundshield Surface Acoustic Wave , Portable Ultrasonic Therapeutic Devices , National Institute , Care Excellence , Medtech Funding Mandate , Coventry University , Assistant Professor , Ksenija Maravic , Annual Report , Quarterly Reports , Managing Principal ,

NanoVibronix Regains Nasdaq Compliance

Press release content from Business Wire. The AP news staff was not involved in its creation.
NanoVibronix Regains Nasdaq Compliance
ELMSFORD, N.Y. (BUSINESS WIRE) Feb 3, 2021
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it received notice from the Nasdaq Listing Qualification Office of The Nasdaq Stock Market LLC (“Nasdaq”) on February 2, 2021 that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (“Min Bid Price Listing Rule”).
ADVERTISEMENT
In addition, on January 4, 2021 the company received notice from Nasdaq that it has regained compliance with the equity requirement under Nasdaq Listing Rule 5550(b)(1). ....

New York , United States , H Efa , Brett Maas , Company Annual Report On Form , Exchange Commission , Nasdaq Listing Qualification Office , Nasdaq Stock Market , Nanovibronix Inc , Surface Acoustic Wave , Portable Ultrasonic Therapeutic Devices , Nasdaq Listing Rule , Bid Price Listing , Nasdaq Capital Market , Listing Qualifications Staff , Annual Report , Quarterly Reports , Investor Contacts , Managing Principal , Business Wire , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஏச் எபா , ப்ரெட் மாஸ் , நிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம் , பரிமாற்றம் தரகு ,